[60]Fullerene Amino Acids and Related Derivatives by Burley, Glenn A et al.
University of Wollongong 
Research Online 
Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 
1-1-1999 
[60]Fullerene Amino Acids and Related Derivatives 
Glenn A. Burley 
University of Wollongong 
Paul A. Keller 
University of Wollongong, keller@uow.edu.au 
Stephen G. Pyne 
University of Wollongong, spyne@uow.edu.au 
Follow this and additional works at: https://ro.uow.edu.au/scipapers 
 Part of the Life Sciences Commons, Physical Sciences and Mathematics Commons, and the Social 
and Behavioral Sciences Commons 
Recommended Citation 
Burley, Glenn A.; Keller, Paul A.; and Pyne, Stephen G.: [60]Fullerene Amino Acids and Related Derivatives 
1999. 
https://ro.uow.edu.au/scipapers/62 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
[60]Fullerene Amino Acids and Related Derivatives 
Abstract 
This paper is a review of the literature concerning the preparation of [60]fullerene amino acid and peptide 
derivatives. The structure and applications of these derivatives to the biological and material sciences is 
also presented. 
Keywords 
fullerene, amino acids, peptides, CMMB 
Disciplines 
Life Sciences | Physical Sciences and Mathematics | Social and Behavioral Sciences 
Publication Details 
This article was originally published as: Burley, GA, Keller, PA & Pyne, SG, [60]Fullerene Amino Acids and 
Related Derivatives, Fullerene Science and Technology, 1999, 7(6), 973-1001. Copyright 1999 Marcel 
Dekker Inc. 
This journal article is available at Research Online: https://ro.uow.edu.au/scipapers/62 
[60]FULLERENE AMINO ACIDS AND RELATED
DERIVATIVES
Glenn A. Burley, Paul A. Keller* and Stephen G. Pyne*
Department of Chemistry, University of Wollongong, Wollongong, New South Wales,
2522, Australia.
ABSTRACT
This paper is a review of the literature concerning the preparation of [60]fullerene amino acid
and peptide derivatives. The structure and applications of these derivatives to the biological
and material sciences is also presented.
INTRODUCTION
Initially thought to be chemically inert, [60]fullerene has been found to react with a wide
range of nucleophiles and radicals and also readily undergoes cycloaddition reactions with
dienes and 1,3-dipoles to produce stable derivatives1-3. More importantly, fullerene derivatives
retain the main features of [60]fullerene such as:
a) precise three dimensional architecture,
b) large hydrophobic mass and,
c) unique electronic properties.
In addition, these derivatives offer the possibility of incorporating useful functionalities for further
chemical manipulation of groups to modify the physical characteristics (e.g. improved solubility in
polar solvents) of [60]fullerene1-3. Thus the ability to derivatise [60]fullerene efficiently whilst
retaining the essential characteristics of [60]fullerene have stimulated much interest in the
applications of fullerenes to materials science and medicinal chemistry.
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One of the most exciting fields of fullerene chemistry is related to their biological activity.
[60]Fullerene derivatives exhibit a range of interesting biological activities including inhibition of
HIV enzymes4-12, photoinduced cytotoxicity via selective cleavage of DNA13-17 and as a smooth
muscle relaxant18-20. In addition, other interesting reports of fullerene derivatives of biologically
significant molecules such as lipids21, saccharides22, oligonucleotides23-24 and amino acids have
appeared in the literature. Of these aforementioned groups, amino acid fullerene derivatives are of
special interest. The covalent tethering of fullerenes to peptides and proteins has been the goal of a
number of studies concerned with the application of fullerene-peptide conjugates to biological
problems25-30. This article will report current progress in the preparation and applications of fulleryl
amino acids and related derivatives.
1.0 PREPARATION OF FULLERENE AMINO ACIDS
Fulleryl amino acid and peptide derivatives have commonly been prepared by first attachment
of a versatile handle widely used in amino acid chemistry, such as hydroxyl, amino or carboxylic
acid functional groups to [60]fullerene followed by coupling to a protected amino acid or peptide.
The methods of preparation of [60]fullerene products suitable for derivatisation with amino acids
and peptides will be first outlined in this review.
1.1.0 Cycloaddition Reactions
Among the various reactions available for derivatisation of [60]fullerene, cycloaddition
reactions are the most numerous. The electron deficient fullerene sphere of [60]fullerene is an
excellent dienophile and dipolarophile with many resulting cycloadducts showing remarkable
stability1-3. This section outlines the range of cycloaddition reactions used to form a suitable handle
for peptide coupling, as well as the formation of fulleroprolines and a fullerylglycine derivative.
1.1.1 [2+1] Cycloaddition
The addition of the carbene or carbenoid derived from [4-tert-
butoxycarbonylphenyl]diazomethane (1) to [60]fullerene and subsequent deprotection of the ester
(2) was the first example of a fulleryl derivative with a convenient handle that was utilised for
peptide functionalisation (Scheme 1)31. Acid-mediated deprotection (trifluoromethanesulfonic acid)
of (2) formed the versatile carboxylic acid (3). Coupling of the pentapeptide H-(L-Ala-Aib)2-L-Ala-
OMe via the acyl chloride (4) yielded the first fullerene peptide (5). Using this versatile synthon (3),

























Alkyl diazoacetates were shown to be just as effective in producing another versatile
synthon, the methanofullerene carboxylic acid (8) (Scheme 2)27,32. The 1,2-dihydro-1,2-
(carboxymethano)-[60]fullerene (7) can be obtained either from the corresponding tert-butyl
carboxylate (6a) or ethoxycarbonylmethyl carboxylate (6b) of the corresponding alkyl
diazoacetate32. Isaacs and Diederich demonstrated that dicyclohexylcarbodiimide (DCC) mediated
amidation of (8) to produce (9) and (10) was just as effective as the acyl chloride coupling methods
used by Prato et al. (1993)25. The dipeptide product was poorly soluble in organic solvents while



























8 R = Hor BBr3, 82%
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In addition to the formation of methanofullerene derivatives via diazomethanes (Scheme 1)
and diazoacetates (Scheme 2), analogous reactions of [60]fullerene with diazoamides (12a-d) have
been successfully carried out (Scheme 3)26. Diazoamide derivatives of protected peptides (12c-d)
can be prepared in high yield by direct diazoacetylation of primary and secondary amino groups in
amino acids with succinimidyl diazoacetate (11)33. The synthesis of (13c-13d) was achieved by
refluxing stoichiometric amounts of [60]fullerene with (11a-d), resulting in a loss of nitrogen and






























a X = morpholenide
b X = benzylamide
c X = Phe-OBz







The above methods using diazo compounds, however, suffer from the formation of two
types of methanofullerenes products. In general, a mixture of [5-6]-position (open) and [6-6]-
position (closed) products are obtained. For example, heating a solution of 6b with [60]fullerene at
reflux affords a mixture of [6-6] closed (14a, methanofullerene) and [5-6] open (14b,
methanoannulene) isomers (Scheme 4). The thermodynamically favourable [6-6] closed adduct is
obtained almost exclusively by refluxing the mixture in toluene for a further two days. The ratio of
14a and 14b varies with alkyl diazo substitution with purification being somewhat difficult as these



























Another versatile fullerene synthon for the preparation of fullerene amino acid derivatives is the
racemic alcohol (18). This compound can be obtained by the addition of 2-trimethylsiloxy-1,3-
butadiene (15) to [60]fullerene in refluxing toluene solution followed by hydrolysis of the
cycloadduct (16) and then reduction of the corresponding ketone (17) with diisobutylaluminium
hydride (DIBAL-H) (Scheme 5)34. Coupling of glutamate and alanine derivatives via DCC-
mediated esterification produces adducts (19) and (20) respectively in high yields. This method
provides a synthesis of amino acid derivatives of potential biological importance under mild









































A hydroxyl group can also be used for amino acid coupling in the cyclopentyl derivative (22)
(Scheme 6). Thermal ring opening of 7-alkylidene-2,3-diazobicycloheptene or
methylenecyclopropanone ketals (21) in the presence of [60]fullerene followed by silica gel
hydrolysis of the ketene acetal gave a mixture of (22) and (23)35. The corresponding fulleryl amino
ester derivatives (26) and (27) were prepared from DCC-coupled esterification of the N-Boc pyrrole
































Organic azides serve as useful 1,3-dipoles and undergo [3+2] cycloaddition reactions (either
photochemically or thermally) with C60 to yield fulleroaziridines (Scheme 7)
37-38. Of these organic
azides, photochemical or thermal reactions of [60]fullerene with perfluorophenyl azides (28)
produces novel fulleroaziridines (29) with an activated N-hydroxysuccinimide ester. This active





























1.1.4 Addition of Azomethine Ylides
The reactions of azomethine ylides with [60]fullerene are the simplest and most efficient
routes to fulleryl amino acids. These reactive 1,3-dipoles can be generated by a number of methods.
The Prato group has used either thermal ring opening of electron deficient aziridines (33) or
iminium salts derived from condensation of amino acid esters (31) with aldehydes (32) to produce
azomethine ylides in situ39,40. The resulting products are exclusively [6-6] adducts, arising from
addition across the [6-6] double bond of [60]fullerene (Scheme 8). These methods allowed the
synthesis of the first fulleryl C-substituted amino acid, more commonly known as fulleroproline
(Fpr, 34)41. These reactions are versatile and a variety of substituted fulleroproline derivatives can

























Fpr derivatives can be prepared with the pyrrolidine nitrogen protected (Scheme 9) or
unprotected (Scheme 10)42. Selective deprotection of the N-protecting group (either trityl or p-
methoxybenzyl) in (36) was achieved in the presence of the methyl ester group using trifluoroacetic
acid (TFA) (Scheme 9). This allows Fpr to be incorporated into peptides using conventional peptide
coupling techniques. The unprotected adduct (40) cannot be isolated as a pure solid due to the
reactivity of the free amino group, but can be stored in the dark and in dilute solutions39,42.
Compound (40) however can be used to prepare either N-terminal peptides [(43) and (44)] or C-
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Diastereoselective additions of azomethine ylides to [60]fullerene have also been reported
(Scheme 11). For example, the reaction of [60]fullerene with the chiral O-protected L-4-
hydroxyproline derivative (47) and formaldehyde gives the fulleroproline derivatives (48a and 48b)
in a diastereoselective fashion43. The presence of the bulky tert-butyldiphenylsiloxy (OTBDPS)
group favours attack of the 1,3-dipole with the bulky OTBDPS group facing away from the
























































Other routes for the preparation of fulleroproline derivatives via azomethine ylides are
shown in Scheme 12. N-Benzylidine imines of amino acids (49) also produce azomethine ylides in
situ and afford Fpr adducts by refluxing a toluene solution of these imines in the presence of
[60]fullerene44-46. The anti and the syn intermediates produced are in thermal equilibrium with the
imine (49) and react with [60]fullerene to produce (50a) and (50b) respectively. The anti
intermediate is thermodynamically less stable than the corresponding syn intermediate since the
phenyl group in the former is not coplanar with the nitrogen atom for steric reasons and thus
adducts of the type 50b are favoured over 50a in these reactions46. Although
pyrrolidino[60]fullerenes are much less basic than their pyrrolidine counterparts, alkylation of
pyrrolidino[60]fullerenes has recently been achieved under mild solvent-free phase transfer
conditions in the presence of microwave radiation47.
1.2.0 Nucleophilic Addition
1.2.1 Addition of Amines
It has been well documented that primary and secondary amines undergo nucleophilic
additions with the electron deficient [60]fullerene. It has been suggested that these adducts are
formed by a stepwise mechanism that involves initial electron transfer followed by radical
recombination48-51. Natural amino acids have a highly nucleophilic primary amine (except for Pro)
and these have been reported to react readily with [60]fullerene to form water-soluble products (52)
(Scheme 13)52-59. The yields for these adducts, however, were not reported. The formation of































1.2.2 Addition of Carbon Nucleophiles
The cyclopropanation of [60]fullerene, first discovered by Bingel, proceeds via the
deprotonation of α−haloesters with base in the presence of [60]fullerene60. This is one of the most
widely used reactions in fullerene chemistry. With the development of a one-pot cyclopropanation
reaction by Camps and Hirsch, this reaction is also one of the most efficient with yields averaging
50% (Scheme 14)61. The reaction involves the formation of the α−haloester (54) in situ by
deprotonation of one methylene proton and bromination using carbon tetrabromide (CBr4). The
resultant α−haloester is deprotonated by a second equivalent of DBU and undergoes nucleophilic
attack of [60]fullerene. Cyclopropanation is complete with the incipient anion of C60 attacking the
electron deficient carbon of the α−haloester and the bromine acting as a leaving group.
Alternatively, the deprotonated α−haloester may undergo α−elimination of the halide to give the
































Up until recently, the versatility of this reaction was confined primarily to malonate
derivatives61. Our group has shown that fulleryl glycine imino esters can be synthesised from
commercially available glycine imino esters under Hirsch cyclopropanation conditions (Scheme
15). For example, treatment of a solution of [60]fullerene with tert-butyl N-
diphenylmethyleneglycinate (57), carbon tetrabromide and diazabicyclo[5.4.0]undec-7-ene (DBU)
gave the cyclopropane imino ester (58)63. As opposed to the literature findings64, (58) was shown to
be remarkably stable under acidic and hydrogenolysis conditions. Treatment of (58) under mild
reductive conditions using sodium cyanoborohydride in mildly acidic media (pH=4), formed not the
reduced imine compound but a novel ring opened 1,2-dihydro[60]fullerylglycine derivative (59).
The two fullerene carbons alpha to C-1 (C-6 and C-9) and C-2 (C-3 and C-12) were observed
downfield of other fullerene resonances and occurred in the region δ154.4-152.4 (Figure 1) in
HMBC experiments. Interestingly, C-6 and C-9 and C-3 and C-12 appeared as diastereotopic pairs
due to the stereogenicity of C-61. This compound, like Fpr, is only the second example (albeit
protected) of a C-substituted fulleryl amino acid. We are currently developing methods to deprotect
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Figure 1. 13C NMR (d6-benzene/CS2, 1 : 1) chemical shifts and 






Photolysis reactions are another method commonly utilised by fullerene chemists to produce
fullerene amino acid derivatives. Fulleroproline derivatives can be formed by photolysis of primary
and secondary amino acid esters (Scheme 16)65-67. The initial key step in these photoreactions is
presumed to be the formation of an α−carbon-centred radical (64) which attacks the fullerene
(Scheme 17). The presence of O2 in the reaction vessel appears to accelerate this photoreaction.
Another interesting result using photolysis of amino acids with [60]fullerene is the photolytic
decarboxylation of (MeOOC)2CH2NCH2COOH to form a 1,2-dihyro[60]fullerene [(70),
R1=CH2(CO2Me)2, R2=H] (Scheme 18)
42. The mechanism, similar to the reaction pathway of the
amino acid ester (Scheme 17), involves the formation of the carboxyl radical (67). Decarboxylation
of (67) forms the aminomethyl radical (69) which undergoes addition to [60]fullerene and H-

































































2.0 APPLICATIONS OF FULLERENE AMINO ACIDS
The potential uses of amino acid and peptide derivatives of fullerenes range from the
biological to the material sciences. This section will outline the major areas of achievement to date.
2.1 Fullerene Peptide Structure
Since the pioneering work by Prato et al.25, several fullerene peptide studies have been
carried out27,68. Spectroscopic data of adduct (5) (Scheme 1) showed this compound exhibited both
fullerene and peptide properties. Using an optically active alanine residue in the peptide chain, the
first example of a chiral fullerene derivative was synthesised. Conformational analysis using 1H-
NMR and FT-IR revealed that an ordered secondary helical structure is adopted, predominantly a
310-helix rather than α−helix. This result is consistent with literature studies of a variety of short
Aib (α−aminoisobutyric acid) rich peptides69. The secondary structure of this peptide sequence
appears not to be affected by the [60]fullerene moiety.
In contrast to the pentapeptide adduct (9), fulleroproline peptide structures incorporate a
chiral Cα directly bonded to the fullerene sphere
42. The stereochemistry of Cα in these
compounds was determined by circular dichroism (CD). The CD spectra of adducts (43-46) were
not particularly successful due to insolubility problems, however, transformation of these adducts
into the corresponding 2,5-dioxopiperazines solved the stereochemical dilemma. CD revealed a
negative Cotton effect corresponding to an S-configuration of Cα in Fpr, whereas a positive Cotton
effect corresponds to an R-configuration. The Fpr dipeptide adducts (43-46) were shown to be
poorly soluble in organic solvents, thus analyses of their secondary structure were not forthcoming.
Conformational characterisation was achieved with the small Fpr peptides (71) and (72)68. In all
these cases, the N-terminus of Fpr was blocked by acylation using isobutyroyl chloride (Ibu-Cl) and
triethylamine (NEt3) to prepare di- and tripeptide derivatives (71) and (72). X-ray diffraction
techniques reveal both peptides (71) and (72) are folded in a type-II β-turn conformation,
characterised by a weak H-bond between the carbonyl of the Ibu group and amide proton of D-































71 72 73  
Although not a Fpr in the strict sense, the fullerene derivative (73) is worthy of mention74.
The [60]fullerene cage is able to reversibly accept up to a maximum of six electrons in optimal
conditions and thus can be detected electrochemically and thus could have uses as a biological
probe75. By coupling the thiol-selective maleimide derivative (73) to the thiol unit in the small
copper-containing protein azurin mutant (containing one surface cysteine residue), the fullerene-
modified protein was detected by UV-vis spectroscopy. Cyclic voltammetry of the fullerene-
modified protein revealed the presence of a new redox couple at –302mV, assigned to the first
reduction and reoxidation of [60]fullerene. A shift to a more negative potential was observed for the
copper containing azurin protein compared to the native protein. The authors suggest this
pronounced change in potential maybe due to communication between the fullerene and the copper
centre.
2.2 Biological Activity
The Prato group using the methanofullerene carboxylic acid (8) shown in Scheme 2
reported the first bioactive peptide (9)27,32. The pentapeptide sequence H-Thr-Thr-Asn-Tyr-Thr-OH
is a known activator of human monocyte chemotaxis. The biological activity of the coupled fulleryl
peptide (9) was evaluated compared to the underivatised peptide, revealing potent chemotaxic
activity, higher than of the underivatised pentapeptide.
Anti-HIV-1 protease (HIV-P) activities were also conducted on compound (9). From studies
of Friedman et al. the [60]fullerene sphere acts as an ideal hydrophobic substrate in the centre of
HIV-P4,5,11. Activity of the pentapeptide coupled fullerene adduct was shown to be moderate with
Ki values ~100µM level. More recent [60]fullerene derivatives have revealed HIV-P activity in the
nanomolar range (Table 1)11. These findings have shown the potential for water soluble
[60]fullerene derivatives to be viable biological agents for diseases such as cancer therapy.
Although the mode of action of water-soluble [60]fullerene derivatives such as (74) have been hotly
debated in the literature, they have shown a potential use for photodynamic therapy76-78. Compound
(74) was shown to be cytotoxic to the HeLa S3 cell line upon short irradiation periods with




























Figure 2: In vitro cytotoxicity of 74 against HeLa S3 cells
R
2.3 Molecular Recognition
[60]Fullerene based HPLC materials have numerous practical applications in both
chromatography and supramolecular chemistry. Fpr derivatives have been successfully coupled to
solid supports on silica gel (Scheme 19)79,80. Packing this solid [60]fullerene matrix as a new HPLC
stationary phase allowed investigation of its chromatographic properties. Initial studies showed that
this new stationary phase is both effective in organic and aqueous media, however differences were
observed with the [60]fullerene stationary silica phase with respect to conventional silica stationary
phases. These differences are due to solute molecules interacting with the fullerene sphere, thus
affecting retention times compared with conventional silica. This is particularly apparent with
cavity-containing molecules such as calix[n]arenes and cyclodextrins. Molecules with a cavity




















Molecular recognition of small peptides was also achieved using this silica gel Fpr matrix.
A number of small helical-shaped peptides containing hydrophobic cavities of various sizes were
successfully separated in aqueous media using the Fpr solid matrix. Helical proteins that comprise a
hydrophobic cleft complementary to the diameter of the grafted [60]fullerene were selectively
retained on the stationary phase.
CONCLUDING REMARKS
In conclusion, a number of novel reactions have been developed to prepare amino acid
[60]fullerene derivatives and their corresponding peptides. Further developments in this area will
see increasing application of these compounds in a variety of areas including materials and
biological sciences.
Notes Added in Proof
Recently published (Da Ros, T., Prato, M. Chem. Commun., 1999, 663-669) was a concise review
describing the medicinal chemistry of some fullerenes. It included a short section on fulleryl amino
acids and peptides.
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